Biocon Biologics to offer 15% stake to Serum Institute Life Sciences September 16, 2021 Auto Bot News 0 Under the alliance, BBL will get committed access to 100 million doses of vaccines annually for 15 years and commercialisation rights of the SILS vaccine portfolio for global markets.